(S)-GSK-3685032 is used as a stereoisomeric control compound in experimental studies; it serves as a non-time-dependent, non-covalent, reversible, and selective DNMT1 inhibitor (IC50 = 0.036 μM), inducing loss of DNA methylation, transcriptional activation, and inhibition of cancer cell growth.